{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:50:49Z","timestamp":1774536649176,"version":"3.50.1"},"reference-count":58,"publisher":"Sociedade Brasileira de Cardiologia","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,11]]},"DOI":"10.36660\/abc.20201257","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T18:47:26Z","timestamp":1647283646000},"page":"646-654","source":"Crossref","is-referenced-by-count":3,"title":["Defici\u00eancia de Ferro na Insufici\u00eancia Card\u00edaca com Fra\u00e7\u00e3o de Eje\u00e7\u00e3o Reduzida: Fisiopatologia, Diagn\u00f3stico e Tratamento"],"prefix":"10.36660","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7833-2994","authenticated-orcid":false,"given":"Guilherme Augusto Reissig","family":"Pereira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5702-210X","authenticated-orcid":false,"given":"Lu\u00eds","family":"Beck-da-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22636","reference":[{"issue":"12","key":"key20220314144714_B1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The Global Health and Economic Burden of Hospitalizations for Heart Failure: Lessons Learned from Hospitalized Heart Failure Registries","volume":"63","author":"Ambrosy","year":"2014","unstructured":"1. Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, et al. The Global Health and Economic Burden of Hospitalizations for Heart Failure: Lessons Learned from Hospitalized Heart Failure Registries. J Am Coll Cardiol. 2014;63(12):1123-33. doi: 10.1016\/j.jacc.2013.11.053.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"key20220314144714_B2","first-page":"29","article-title":"The Economic Burden of Heart Conditions in Brazil","volume":"111","author":"Stevens","year":"2018","unstructured":"2. Stevens B, Pezzullo L, Verdian L, Tomlinson J, George A, Bacal F. The Economic Burden of Heart Conditions in Brazil. Arq Bras Cardiol. 2018;111(1):29-36. doi: 10.5935\/abc.20180104.","journal-title":"Arq Bras Cardiol"},{"issue":"6","key":"key20220314144714_B3","first-page":"433","article-title":"I Brazilian Registry of Heart Failure - Clinical Aspects, Care Quality and Hospitalization Outcomes","volume":"104","author":"Albuquerque","year":"2015","unstructured":"3. Albuquerque DC, Souza Neto JD, Bacal F, Rohde LE, Bernardez-Pereira S, Berwanger O, et al. I Brazilian Registry of Heart Failure - Clinical Aspects, Care Quality and Hospitalization Outcomes. Arq Bras Cardiol. 2015;104(6):433-42. doi: 10.5935\/abc.20150031.","journal-title":"Arq Bras Cardiol"},{"issue":"6","key":"key20220314144714_B4","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jamainternmed.2015.0924","article-title":"A Contemporary Appraisal of the Heart Failure Epidemic in Olmsted County, Minnesota, 2000 to 2010","volume":"175","author":"Gerber","year":"2015","unstructured":"4. Gerber Y, Weston SA, Redfield MM, Chamberlain AM, Manemann SM, Jiang R, et al. A Contemporary Appraisal of the Heart Failure Epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med. 2015;175(6):996-1004. doi: 10.1001\/jamainternmed.2015.0924.","journal-title":"JAMA Intern Med"},{"issue":"10","key":"key20220314144714_B5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association","volume":"135","author":"Benjamin","year":"2017","unstructured":"5. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017;135(10):146-603. doi: 10.1161\/CIR.0000000000000485.","journal-title":"Circulation"},{"issue":"20","key":"key20220314144714_B6","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/CIRCULATIONAHA.105.583666","article-title":"Anemia in Chronic Heart Failure: Prevalence, Etiology, Clinical Correlates, and Treatment Options","volume":"113","author":"Tang","year":"2006","unstructured":"6. Tang YD, Katz SD. Anemia in Chronic Heart Failure: Prevalence, Etiology, Clinical Correlates, and Treatment Options. Circulation. 2006;113(20):2454-61. doi: 10.1161\/CIRCULATIONAHA.105.583666.","journal-title":"Circulation"},{"key":"key20220314144714_B7","first-page":"5","article-title":"Report of a WHO Scientific Group","volume":"405","author":"Nutritional Anaemias","year":"1968","unstructured":"7. Nutritional Anaemias. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser. 1968;405:5-37.","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"3","key":"key20220314144714_B8","first-page":"436","article-title":"Diretriz Brasileira de Insufici\u00eancia Card\u00edaca Cr\u00f4nica e Aguda","volume":"111","author":"Rohde","year":"2018","unstructured":"8. Rohde LEP, Montera MW, Bocchi EA, Clausell NO, Albuquerque DC, Rassi S, et al. Diretriz Brasileira de Insufici\u00eancia Card\u00edaca Cr\u00f4nica e Aguda. Arq Bras Cardiol. 2018;111(3):436-539. doi: 10.5935\/abc.20180190.","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"key20220314144714_B9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchf.2018.07.015","article-title":"Iron Deficiency in Heart Failure: An Overview","volume":"7","author":"von Haehling","year":"2019","unstructured":"9. von Haehling S, Ebner N, Evertz R, Ponikowski P, Anker SD. Iron Deficiency in Heart Failure: An Overview. JACC Heart Fail. 2019;7(1):36-46. doi: 10.1016\/j.jchf.2018.07.015.","journal-title":"JACC Heart Fail"},{"issue":"7","key":"key20220314144714_B10","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jacc.2017.12.027","article-title":"The Burden of Iron Deficiency in Heart Failure: Therapeutic Approach","volume":"71","author":"Rocha","year":"2018","unstructured":"10. Rocha BML, Cunha GJL, Falc\u00e3o LFM. The Burden of Iron Deficiency in Heart Failure: Therapeutic Approach. J Am Coll Cardiol. 2018;71(7):782-93. doi: 10.1016\/j.jacc.2017.12.027.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"key20220314144714_B11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron Deficiency in Chronic Heart failure: an International Pooled Analysis","volume":"165","author":"Klip","year":"2013","unstructured":"11. Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, et al. Iron Deficiency in Chronic Heart failure: an International Pooled Analysis. Am Heart J. 2013;165(4):575-82. doi: 10.1016\/j.ahj.2013.01.017.","journal-title":"Am Heart J"},{"issue":"15","key":"key20220314144714_B12","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron Deficiency: An Ominous Sign in Patients with Systolic Chronic Heart Failure","volume":"31","author":"Jankowska","year":"2010","unstructured":"12. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, et al. Iron Deficiency: An Ominous Sign in Patients with Systolic Chronic Heart Failure. Eur Heart J. 2010;31(15):1872-80. doi: 10.1093\/eurheartj\/ehq158.","journal-title":"Eur Heart J"},{"issue":"11","key":"key20220314144714_B13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/eurheartj\/ehs224","article-title":"Iron Deficiency and Heart Failure: Diagnostic Dilemmas and Therapeutic Perspectives","volume":"34","author":"Jankowska","year":"2013","unstructured":"13. Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P. Iron Deficiency and Heart Failure: Diagnostic Dilemmas and Therapeutic Perspectives. Eur Heart J. 2013;34(11):816-29. doi: 10.1093\/eurheartj\/ehs224.","journal-title":"Eur Heart J"},{"issue":"1","key":"key20220314144714_B14","first-page":"5","article-title":"Normal Iron Metabolism and the Pathophysiology of Iron Overload Disorders","volume":"27","author":"Siah","year":"2006","unstructured":"14. Siah CW, Ombiga J, Adams LA, Trinder D, Olynyk JK. Normal Iron Metabolism and the Pathophysiology of Iron Overload Disorders. Clin Biochem Rev. 2006;27(1):5-16.","journal-title":"Clin Biochem Rev"},{"issue":"4","key":"key20220314144714_B15","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.ajkd.2009.12.030","article-title":"Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD","volume":"55","author":"Babitt","year":"2010","unstructured":"15. Babitt JL, Lin HY. Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD. Am J Kidney Dis. 2010;55(4):726-41. doi: 10.1053\/j.ajkd.2009.12.030.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"key20220314144714_B16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/jcp.2010.079046","article-title":"Disorders of Iron Metabolism. Part 1: Molecular Basis of Iron Homoeostasis","volume":"64","author":"Mu\u00f1oz","year":"2011","unstructured":"16. Mu\u00f1oz M, Garc\u00eda-Erce JA, Remacha AF. Disorders of Iron Metabolism. Part 1: Molecular Basis of Iron Homoeostasis. J Clin Pathol. 2011;64(4):281-6. doi: 10.1136\/jcp.2010.079046.","journal-title":"J Clin Pathol"},{"issue":"6","key":"key20220314144714_B17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/clc.22956","article-title":"Changes in Myocardial Iron Content Following Administration of Intravenous Iron (Myocardial-IRON): Study Design","volume":"41","author":"Mi\u00f1ana","year":"2018","unstructured":"17. Mi\u00f1ana G, Cardells I, Palau P, Ll\u00e0cer P, F\u00e1cila L, Almenar L, et al. Changes in Myocardial Iron Content Following Administration of Intravenous Iron (Myocardial-IRON): Study Design. Clin Cardiol. 2018;41(6):729-35. doi: 10.1002\/clc.22956.","journal-title":"Clin Cardiol"},{"issue":"4","key":"key20220314144714_B18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1056\/NEJMcibr1112780","article-title":"Closing the Iron Gate","volume":"366","author":"Andrews","year":"2012","unstructured":"18. Andrews NC. Closing the Iron Gate. N Engl J Med. 2012;366(4):376-7. doi: 10.1056\/NEJMcibr1112780.","journal-title":"N Engl J Med"},{"issue":"3","key":"key20220314144714_B19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1042\/CS20040278","article-title":"Dietary Iron Deficiency Induces Ventricular Dilation, Mitochondrial Ultrastructural Aberrations and Cytochrome c Release: Involvement of Nitric Oxide Synthase and Protein Tyrosine Nitration","volume":"109","author":"Dong","year":"2005","unstructured":"19. Dong F, Zhang X, Culver B, Chew HG Jr, Kelley RO, Ren J. Dietary Iron Deficiency Induces Ventricular Dilation, Mitochondrial Ultrastructural Aberrations and Cytochrome c Release: Involvement of Nitric Oxide Synthase and Protein Tyrosine Nitration. Clin Sci (Lond). 2005;109(3):277-86. doi: 10.1042\/CS20040278.","journal-title":"Clin Sci (Lond)"},{"issue":"7","key":"key20220314144714_B20","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ejhf.467","article-title":"The Influence of Iron Deficiency on the Functioning of Skeletal Muscles: Experimental Evidence and Clinical Implications","volume":"18","author":"Stugiewicz","year":"2016","unstructured":"20. Stugiewicz M, Tkaczyszyn M, Kasztura M, Banasiak W, Ponikowski P, Jankowska EA. The Influence of Iron Deficiency on the Functioning of Skeletal Muscles: Experimental Evidence and Clinical Implications. Eur J Heart Fail. 2016;18(7):762-73. doi: 10.1002\/ejhf.467.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"key20220314144714_B21","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jacc.2011.01.059","article-title":"Myocardial and Systemic iron Depletion in Heart Failure Implications for Anemia Accompanying Heart Failure","volume":"58","author":"Maeder","year":"2011","unstructured":"21. Maeder MT, Khammy O, Remedios C, Kaye DM. Myocardial and Systemic iron Depletion in Heart Failure Implications for Anemia Accompanying Heart Failure. J Am Coll Cardiol. 2011;58(5):474-80. doi: 10.1016\/j.jacc.2011.01.059.","journal-title":"J Am Coll Cardiol"},{"issue":"44","key":"key20220314144714_B22","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1093\/eurheartj\/ehz680","article-title":"Iron Deficiency in Worsening Heart Failure is Associated with Reduced Estimated Protein Intake, Fluid Retention, Inflammation, and Antiplatelet Use","volume":"40","author":"van der Wal","year":"2019","unstructured":"22. van der Wal HH, Beverborg NG, Dickstein K, Anker SD, Lang CC, Ng LL, et al. Iron Deficiency in Worsening Heart Failure is Associated with Reduced Estimated Protein Intake, Fluid Retention, Inflammation, and Antiplatelet Use. Eur Heart J. 2019;40(44):3616-25. doi: 10.1093\/eurheartj\/ehz680.","journal-title":"Eur Heart J"},{"issue":"12","key":"key20220314144714_B23","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/ejhf.1305","article-title":"Screening, Diagnosis and Treatment of Iron Deficiency in Chronic Heart Failure: Putting the 2016 European Society of Cardiology Heart Failure Guidelines into Clinical Practice","volume":"20","author":"McDonagh","year":"2018","unstructured":"23. McDonagh T, Damy T, Doehner W, Lam CSP, Sindone A, van der Meer P, et al. Screening, Diagnosis and Treatment of Iron Deficiency in Chronic Heart Failure: Putting the 2016 European Society of Cardiology Heart Failure Guidelines into Clinical Practice. Eur J Heart Fail. 2018;20(12):1664-72. doi: 10.1002\/ejhf.1305.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"key20220314144714_B24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000342110","article-title":"Anemia in Heart Failure: Association of Hepcidin Levels to Iron Deficiency in Stable Outpatients","volume":"129","author":"Weber","year":"2013","unstructured":"24. Weber CS, Beck-da-Silva L, Goldraich LA, Biolo A, Clausell N. Anemia in Heart Failure: Association of Hepcidin Levels to Iron Deficiency in Stable Outpatients. Acta Haematol. 2013;129(1):55-61. doi: 10.1159\/000342110.","journal-title":"Acta Haematol"},{"issue":"10","key":"key20220314144714_B25","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of Chronic Disease","volume":"352","author":"Weiss","year":"2005","unstructured":"25. Weiss G, Goodnough LT. Anemia of Chronic Disease. N Engl J Med. 2005;352(10):1011-23. doi: 10.1056\/NEJMra041809.","journal-title":"N Engl J Med"},{"issue":"12","key":"key20220314144714_B26","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.jacc.2006.08.034","article-title":"Etiology of Anemia in Patients with Advanced Heart Failure","volume":"48","author":"Nanas","year":"2006","unstructured":"26. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, et al. Etiology of Anemia in Patients with Advanced Heart Failure. J Am Coll Cardiol. 2006;48(12):2485-9. doi: 10.1016\/j.jacc.2006.08.034.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"key20220314144714_B27","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). Developed with the Special Contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","unstructured":"27. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). Developed with the Special Contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891-975. doi: 10.1002\/ejhf.592.","journal-title":"Eur J Heart Fail"},{"key":"key20220314144714_B28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2215\/CJN.01490506","article-title":"Assessing Iron Status: Beyond Serum Ferritin and Transferrin Saturation","volume":"1","author":"Wish","year":"2006","unstructured":"28. Wish JB. Assessing Iron Status: Beyond Serum Ferritin and Transferrin Saturation. Clin J Am Soc Nephrol. 2006;1 (Suppl 1):4-8. doi: 10.2215\/CJN.01490506.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"key20220314144714_B29","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"70","author":"Yancy","year":"2017","unstructured":"29. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017;70(6):776-803. doi: 10.1016\/j.jacc.2017.04.025.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"key20220314144714_B30","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.ijcard.2013.04.181","article-title":"IRON-HF Study: A Randomized Trial to Assess the Effects of Iron in Heart Failure Patients with Anemia","volume":"168","author":"Beck-da-Silva","year":"2013","unstructured":"30. Beck-da-Silva L, Piardi D, Soder S, Rohde LE, Pereira-Barretto AC, Albuquerque D, et al. IRON-HF Study: A Randomized Trial to Assess the Effects of Iron in Heart Failure Patients with Anemia. Int J Cardiol. 2013;168(4):3439-42. doi: 10.1016\/j.ijcard.2013.04.181.","journal-title":"Int J Cardiol"},{"issue":"19","key":"key20220314144714_B31","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of Oral Iron Repletion on Exercise Capacity in Patients with Heart Failure with Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial","volume":"317","author":"Lewis","year":"2017","unstructured":"31. Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker GM, et al. Effect of Oral Iron Repletion on Exercise Capacity in Patients with Heart Failure with Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial. JAMA. 2017;317(19):1958-66. doi: 10.1001\/jama.2017.5427.","journal-title":"JAMA"},{"issue":"2","key":"key20220314144714_B32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of Intravenous Iron Sucrose on Exercise Tolerance in Anemic and Nonanemic Patients with Symptomatic Chronic Heart Failure and Iron Deficiency FERRIC-HF: A Randomized, Controlled, Observer-Blinded Trial","volume":"51","author":"Okonko","year":"2008","unstructured":"32. Okonko DO, Grzeslo A, Witkowski T, Mandal AK, Slater RM, Roughton M, et al. Effect of Intravenous Iron Sucrose on Exercise Tolerance in Anemic and Nonanemic Patients with Symptomatic Chronic Heart Failure and Iron Deficiency FERRIC-HF: A Randomized, Controlled, Observer-Blinded Trial. J Am Coll Cardiol. 2008;51(2):103-12. doi: 10.1016\/j.jacc.2007.09.036.","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"key20220314144714_B33","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous Iron Reduces NT-pro-brain Natriuretic Peptide in Anemic Patients with Chronic Heart Failure and Renal Insufficiency","volume":"50","author":"Toblli","year":"2007","unstructured":"33. Toblli JE, Lombra\u00f1a A, Duarte P, Di Gennaro F. Intravenous Iron Reduces NT-pro-brain Natriuretic Peptide in Anemic Patients with Chronic Heart Failure and Renal Insufficiency. J Am Coll Cardiol. 2007;50(17):1657-65. doi: 10.1016\/j.jacc.2007.07.029.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"key20220314144714_B34","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency","volume":"361","author":"Anker","year":"2009","unstructured":"34. Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. N Engl J Med. 2009;361(25):2436-48. doi: 10.1056\/NEJMoa0908355.","journal-title":"N Engl J Med"},{"issue":"11","key":"key20220314144714_B35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial Effects of Long-term Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Symptomatic Heart Failure and Iron Deficiency\u2020","volume":"36","author":"Ponikowski","year":"2015","unstructured":"35. Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, et al. Beneficial Effects of Long-term Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Symptomatic Heart Failure and Iron Deficiency\u2020. Eur Heart J. 2015;36(11):657-68. doi: 10.1093\/eurheartj\/ehu385.","journal-title":"Eur Heart J"},{"issue":"8","key":"key20220314144714_B36","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/eurheartj\/ehi162","article-title":"Six Minute Corridor Walk Test as an Outcome Measure for the Assessment of Treatment in Randomized, Blinded Intervention Trials of Chronic Heart Failure: A Systematic Review","volume":"26","author":"Olsson","year":"2005","unstructured":"36. Olsson LG, Swedberg K, Clark AL, Witte KK, Cleland JG. Six Minute Corridor Walk Test as an Outcome Measure for the Assessment of Treatment in Randomized, Blinded Intervention Trials of Chronic Heart Failure: A Systematic Review. Eur Heart J. 2005;26(8):778-93. doi: 10.1093\/eurheartj\/ehi162.","journal-title":"Eur Heart J"},{"issue":"7","key":"key20220314144714_B37","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ejhf.473","article-title":"Effects of Intravenous Iron Therapy in Iron-Deficient Patients with Systolic Heart Failure: A Meta-Analysis of Randomized Controlled Trials","volume":"18","author":"Jankowska","year":"2016","unstructured":"37. Jankowska EA, Tkaczyszyn M, Suchocki T, Drozd M, von Haehling S, Doehner W, et al. Effects of Intravenous Iron Therapy in Iron-Deficient Patients with Systolic Heart Failure: A Meta-Analysis of Randomized Controlled Trials. Eur J Heart Fail. 2016;18(7):786-95. doi: 10.1002\/ejhf.473.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"key20220314144714_B38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ejhf.823","article-title":"Effects of Ferric Carboxymaltose on Hospitalisations and Mortality Rates in Iron-Deficient Heart Failure Patients: An Individual Patient Data Meta-Analysis","volume":"20","author":"Anker","year":"2018","unstructured":"38. Anker SD, Kirwan BA, van Veldhuisen DJ, Filippatos G, Comin-Colet J, Ruschitzka F, et al. Effects of Ferric Carboxymaltose on Hospitalisations and Mortality Rates in Iron-Deficient Heart Failure Patients: An Individual Patient Data Meta-Analysis. Eur J Heart Fail. 2018;20(1):125-33. doi: 10.1002\/ejhf.823.","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"key20220314144714_B39","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/ejhf.837","article-title":"Iron Status and Inflammatory Biomarkers in Patients with Acutely Decompensated Heart Failure: Early in-Hospital Phase and 30-day Follow-up","volume":"19","author":"van Aelst","year":"2017","unstructured":"39. van Aelst LNL, Abraham M, Sadoune M, Lefebvre T, Manivet P, Logeart D, et al. Iron Status and Inflammatory Biomarkers in Patients with Acutely Decompensated Heart Failure: Early in-Hospital Phase and 30-day Follow-up. Eur J Heart Fail. 2017;19(8):1075-6. doi: 10.1002\/ejhf.837.","journal-title":"Eur J Heart Fail"},{"issue":"36","key":"key20220314144714_B40","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1093\/eurheartj\/ehu235","article-title":"Iron Deficiency Defined as Depleted Iron Stores Accompanied by Unmet Cellular Iron Requirements Identifies Patients at the Highest Risk of Death After an Episode of Acute Heart Failure","volume":"35","author":"Jankowska","year":"2014","unstructured":"40. Jankowska EA, Kasztura M, Sokolski M, Bronisz M, Nawrocka S, Ole\u015bkowska-Florek W, et al. Iron Deficiency Defined as Depleted Iron Stores Accompanied by Unmet Cellular Iron Requirements Identifies Patients at the Highest Risk of Death After an Episode of Acute Heart Failure. Eur Heart J. 2014;35(36):2468-76. doi: 10.1093\/eurheartj\/ehu235.","journal-title":"Eur Heart J"},{"issue":"3","key":"key20220314144714_B41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.recesp.2015.08.017","article-title":"Iron Status in Chronic Heart Failure: Impact on Symptoms, Functional Class and Submaximal Exercise Capacity","volume":"69","author":"Enjuanes","year":"2016","unstructured":"41. Enjuanes C, Bruguera J, Grau M, Cladellas M, Gonzalez G, Mero\u00f1o O, et al. Iron Status in Chronic Heart Failure: Impact on Symptoms, Functional Class and Submaximal Exercise Capacity. Rev Esp Cardiol (Engl Ed). 2016;69(3):247-55. doi: 10.1016\/j.rec.2015.08.018.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"1","key":"key20220314144714_B42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijcard.2011.08.006","article-title":"Myocardial Iron Homeostasis in Advanced Chronic Heart Failure Patients","volume":"159","author":"Leszek","year":"2012","unstructured":"42. Leszek P, Sochanowicz B, Szperl M, Kolsut P, Brz\u00f3ska K, Piotrowski W, et al. Myocardial Iron Homeostasis in Advanced Chronic Heart Failure Patients. Int J Cardiol. 2012;159(1):47-52. doi: 10.1016\/j.ijcard.2011.08.006.","journal-title":"Int J Cardiol"},{"issue":"4","key":"key20220314144714_B43","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ejhf.640","article-title":"Myocardial Iron Content and Mitochondrial Function in Human Heart Failure: A Direct Tissue Analysis","volume":"19","author":"Melenovsky","year":"2017","unstructured":"43. Melenovsky V, Petrak J, Mracek T, Benes J, Borlaug BA, Nuskova H, et al. Myocardial Iron Content and Mitochondrial Function in Human Heart Failure: A Direct Tissue Analysis. Eur J Heart Fail. 2017;19(4):522-30. doi: 10.1002\/ejhf.640.","journal-title":"Eur J Heart Fail"},{"issue":"10 Pt A","key":"key20220314144714_B44","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jcmg.2017.08.005","article-title":"Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy","volume":"10","author":"Patel","year":"2017","unstructured":"44. Patel AR, Kramer CM. Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy. JACC Cardiovasc Imaging. 2017;10(10 Pt A):1180-93. doi: 10.1016\/j.jcmg.2017.08.005.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"23","key":"key20220314144714_B45","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2-star (T2*) Magnetic Resonance for the Early Diagnosis of Myocardial Iron Overload","volume":"22","author":"Anderson","year":"2001","unstructured":"45. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, et al. Cardiovascular T2-star (T2*) Magnetic Resonance for the Early Diagnosis of Myocardial Iron Overload. Eur Heart J. 2001;22(23):2171-9. doi: 10.1053\/euhj.2001.2822.","journal-title":"Eur Heart J"},{"issue":"6","key":"key20220314144714_B46","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.amjcard.2013.11.061","article-title":"Quantification of Myocardial Iron Deficiency in Nonischemic Heart Failure by Cardiac T2* Magnetic Resonance Imaging","volume":"113","author":"Nagao","year":"2014","unstructured":"46. Nagao M, Matsuo Y, Kamitani T, Yonezawa M, Yamasaki Y, Kawanami S, et al. Quantification of Myocardial Iron Deficiency in Nonischemic Heart Failure by Cardiac T2* Magnetic Resonance Imaging. Am J Cardiol. 2014;113(6):1024-30. doi: 10.1016\/j.amjcard.2013.11.061.","journal-title":"Am J Cardiol"},{"issue":"4","key":"key20220314144714_B47","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014254","article-title":"Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial","volume":"9","author":"N\u00fa\u00f1ez","year":"2020","unstructured":"47. N\u00fa\u00f1ez J, Mi\u00f1ana G, Cardells I, Palau P, Ll\u00e0cer P, F\u00e1cila L, et al. Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial. J Am Heart Assoc. 2020;9(4):e014254. doi: 10.1161\/JAHA.119.014254.","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"key20220314144714_B48","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/eurjhf\/hfs083","article-title":"Health Economic Assessment of Ferric Carboxymaltose in Patients with Iron Deficiency and Chronic Heart Failure Based on the FAIR-HF Trial: An Analysis for the UK","volume":"14","author":"Gutzwiller","year":"2012","unstructured":"48. Gutzwiller FS, Schwenkglenks M, Blank PR, Braunhofer PG, Mori C, Szucs TD, et al. Health Economic Assessment of Ferric Carboxymaltose in Patients with Iron Deficiency and Chronic Heart Failure Based on the FAIR-HF Trial: An Analysis for the UK. Eur J Heart Fail. 2012;14(7):782-90. doi: 10.1093\/eurjhf\/hfs083.","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"key20220314144714_B49","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10198-013-0533-9","article-title":"Budget Impact of Parenteral Iron Treatment of Iron Deficiency: Methodological Issues Raised by Using Real-Life Data","volume":"15","author":"Brock","year":"2014","unstructured":"49. Brock E, Braunhofer P, Troxler J, Schneider H. Budget Impact of Parenteral Iron Treatment of Iron Deficiency: Methodological Issues Raised by Using Real-Life Data. Eur J Health Econ. 2014;15(9):907-16. doi: 10.1007\/s10198-013-0533-9.","journal-title":"Eur J Health Econ"},{"key":"key20220314144714_B50","year":"2021","unstructured":"50. Ferinject (ferric carboxymaltose) - Summary of Product Characteristics (SmPC) [Internet]. London: Electronic Medicines Compendium; 2021 [cited 2020 Apr 05]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/5910\/smpc.","journal-title":"Ferinject (ferric carboxymaltose) - Summary of Product Characteristics (SmPC)"},{"issue":"12","key":"key20220314144714_B51","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/ejhf.1710","article-title":"Rationale and Design of the AFFIRM-AHF Trial: A Randomised, Double-blind, Placebo-controlled Trial Comparing the Effect of Intravenous Ferric Carboxymaltose on Hospitalisations and Mortality in Iron-deficient Patients Admitted for Acute Heart Failure","volume":"21","author":"Ponikowski","year":"2019","unstructured":"51. Ponikowski P, Kirwan BA, Anker SD, Dorobantu M, Drozdz J, Fabien V, et al. Rationale and Design of the AFFIRM-AHF Trial: A Randomised, Double-blind, Placebo-controlled Trial Comparing the Effect of Intravenous Ferric Carboxymaltose on Hospitalisations and Mortality in Iron-deficient Patients Admitted for Acute Heart Failure. Eur J Heart Fail. 2019;21(12):1651-8. doi: 10.1002\/ejhf.1710.","journal-title":"Eur J Heart Fail"},{"issue":"10266","key":"key20220314144714_B52","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric Carboxymaltose for Iron Deficiency at Discharge After Acute Heart Failure: A Multicentre, Double-blind, Randomised, Controlled Trial","volume":"396","author":"Ponikowski","year":"2020","unstructured":"52. Ponikowski P, Kirwan BA, Anker SD, McDonagh T, Dorobantu M, Drozdz J, et al. Ferric Carboxymaltose for Iron Deficiency at Discharge After Acute Heart Failure: A Multicentre, Double-blind, Randomised, Controlled Trial. Lancet. 2020;396(10266):1895-904. doi: 10.1016\/S0140-6736(20)32339-4.","journal-title":"Lancet"},{"issue":"2","key":"key20220314144714_B53","article-title":"Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients","volume":"11","author":"Beverborg","year":"2018","unstructured":"53. Beverborg NG, Klip IT, Meijers WC, Voors AA, Vegter EL, van der Wal HH, et al. Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients. Circ Heart Fail. 2018;11(2):e004519. doi: 10.1161\/CIRCHEARTFAILURE.117.004519.","journal-title":"Circ Heart Fail"},{"key":"key20220314144714_B54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijcard.2017.04.110","article-title":"Clinical Correlates and Prognostic Impact of Impaired Iron Storage Versus Impaired Iron Transport in an International Cohort of 1821 Patients with Chronic Heart Failure","volume":"243","author":"Moliner","year":"2017","unstructured":"54. Moliner P, Jankowska EA, van Veldhuisen DJ, Farre N, Rozentryt P, Enjuanes C, et al. Clinical Correlates and Prognostic Impact of Impaired Iron Storage Versus Impaired Iron Transport in an International Cohort of 1821 Patients with Chronic Heart Failure. Int J Cardiol. 2017;243:360-6. doi: 10.1016\/j.ijcard.2017.04.110.","journal-title":"Int J Cardiol"},{"key":"key20220314144714_B55","year":"2021","unstructured":"55. Clinical Trials Register [Internet]. Brussels: European Union; 2021 [cited 2020 Ap 05]. Available from: https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2016-000068-40\/PT.","journal-title":"Clinical Trials Register"},{"issue":"1","key":"key20220314144714_B56","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001012","article-title":"Iron Deficiency in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis","volume":"6","author":"Beale","year":"2019","unstructured":"56. Beale AL, Warren JL, Roberts N, Meyer P, Townsend NP, Kaye D. Iron Deficiency in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis. Open Heart. 2019;6(1):e001012. doi: 10.1136\/openhrt-2019-001012.","journal-title":"Open Heart"},{"key":"key20220314144714_B57","year":"2021","unstructured":"57. Effect of IV Iron in Patients with Heart Failure with Preserved Ejection Fraction - Full Text View. Bethesda: ClinicalTrials; 2021 [cited 2020 Sep 16]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03074591.","journal-title":"Effect of IV Iron in Patients with Heart Failure with Preserved Ejection Fraction - Full Text View"},{"issue":"15","key":"key20220314144714_B58","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of Ferric Carboxymaltose on Exercise Capacity in Patients with Chronic Heart Failure and Iron Deficiency","volume":"136","author":"van Veldhuisen","year":"2017","unstructured":"58. van Veldhuisen DJ, Ponikowski P, van der Meer P, Metra M, B\u00f6hm M, Doletsky A, et al. Effect of Ferric Carboxymaltose on Exercise Capacity in Patients with Chronic Heart Failure and Iron Deficiency. Circulation. 2017;136(15):1374-83. doi: 10.1161\/CIRCULATIONAHA.117.027497.","journal-title":"Circulation"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/abccardiol.org\/article\/deficiencia-de-ferro-na-insuficiencia-cardiaca-com-fracao-de-ejecao-reduzida-fisiopatologia-diagnostico-e-tratamento\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:08:09Z","timestamp":1747400889000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/deficiencia-de-ferro-na-insuficiencia-cardiaca-com-fracao-de-ejecao-reduzida-fisiopatologia-diagnostico-e-tratamento\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,11]]}},"alternative-id":["10.36660\/abc.20201257"],"URL":"https:\/\/doi.org\/10.36660\/abc.20201257","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"value":"0066-782X","type":"print"},{"value":"1678-4170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}